Clinical Trial Detail

NCT ID NCT01183559
Title A Trial of ZD6474 (Zactima), Paclitaxel, Carboplatin, 5-Fluorouracil, and XRT Followed by Surgery
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications

gastroesophageal junction adenocarcinoma

esophageal carcinoma

stomach carcinoma

Therapies

Carboplatin + Fluorouracil + Paclitaxel + Vandetanib

Age Groups: adult

No variant requirements are available.